NCT04357704

Brief Summary

The aim of the study is to evaluate the interaural time difference (ITD) benefit in patients with bilateral cochlear implants and to assess speech performance in noisy conditions compared to normal hearing listeners. Half of participants are bilateral cochlear implants users, while the other are normal hearing listeners.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Apr 2019

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 27, 2018

Completed
4 months until next milestone

Study Start

First participant enrolled

April 1, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2019

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2019

Completed
8 months until next milestone

First Posted

Study publicly available on registry

April 22, 2020

Completed
Last Updated

August 3, 2025

Status Verified

July 1, 2025

Enrollment Period

2 months

First QC Date

November 27, 2018

Last Update Submit

July 30, 2025

Conditions

Keywords

Iteraural Time Difference

Outcome Measures

Primary Outcomes (1)

  • speech reception threshold (SRT) in bilateral cochlear implant user with ITD cue

    SRT is used as an outcome measure to quantify the acuity for speech perception in noise with Interaural Time Difference between the two ears. Signal recognition in a background noise is assessed the following conditions S0N0, S0N500, S0N1000, S-500N500 et S0Nuncorr. The noise level is constant at 65 dB SPL, the signal level is modified in the adaptive procedure in order to converge towards a score of 50% of correct response.

    day 0

Secondary Outcomes (3)

  • speech reception threshold (SRT) in bilateral cochlear implant user without ITD cue and in normal hearing listeners

    day 0

  • ITD sensitivity in bilateral cochlear implant user

    day 0

  • Preferred jitter in bilateral cochlear implant user

    day 0

Study Arms (2)

bilateral cochlear implant recipients

EXPERIMENTAL
Other: S0N0Other: S0N500Other: S-500N500Other: S0N1000Other: S0Nuncorr

normal hearing listners

ACTIVE COMPARATOR
Other: S0N0Other: S0N500Other: S-500N500Other: S0N1000Other: S0Nuncorr

Interventions

S0N0OTHER

(no ITD)

bilateral cochlear implant recipientsnormal hearing listners
S0N500OTHER

(ITD +500µs on noise)

bilateral cochlear implant recipientsnormal hearing listners

(ITD -500µs on signal and +500 µs on noise)

bilateral cochlear implant recipientsnormal hearing listners
S0N1000OTHER

(ITD + 1000 µs on noise)

bilateral cochlear implant recipientsnormal hearing listners

(no ITD cue, with uncorrelated stimulation frame)

bilateral cochlear implant recipientsnormal hearing listners

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Fluent in local language
  • Normal hearing listener:
  • pure tone threshold \> 25dB from 125Hz to 12kHz
  • Cochlear implant recipient
  • Digisonic SP® cochlear implants user

You may not qualify if:

  • binaural sensitivity threshold \< 1000µs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Conditions

Hearing Loss, Sensorineural

Condition Hierarchy (Ancestors)

Hearing LossHearing DisordersEar DiseasesOtorhinolaryngologic DiseasesSensation DisordersNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Nicolas Guevara, MD

    Hospital University Nice-IUFC

    PRINCIPAL INVESTIGATOR
  • Alexis Bozorg-Grayeli, MD

    Hospital University Dijon-François Mitterrand

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
PARALLEL
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 27, 2018

First Posted

April 22, 2020

Study Start

April 1, 2019

Primary Completion

June 1, 2019

Study Completion

September 1, 2019

Last Updated

August 3, 2025

Record last verified: 2025-07

Data Sharing

IPD Sharing
Will not share